• Sonuç bulunamadı

Klinik Araştırma ÖZET

N/A
N/A
Protected

Academic year: 2022

Share "Klinik Araştırma ÖZET"

Copied!
5
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

ÖZET

Amaç: Akut bronşiyolit tedavisinde nebülize beta agonist, nebülize steroid ve sistemik steroid tedavisi kullanılmakla birlikte etkinliği konusunda görüş birliği yoktur. Bu çalışmada akut bronşiyolit tedavisinde tartışmalı olan bu ajanların klinik etkinliğinin karşılaştırılması planlan- mıştır.

Gereç ve Yöntem: Çalışmaya Mayıs 2004-Ocak 2005 tarihleri arasında acil gözlem ünitesine akut bronşiyolit tanısı ile yatırılan 2 ay-2 yaş arası 360 çocuk alınmıştır. Hastalar randomize olarak 3 tedavi grubuna ayrılmış; Grup A’ya ardışık 3 doz nebülize beta agonist, Grup B’ye ardışık olarak nebülize beta agonist+nebülize steroid, Grup C’ye ardışık olarak nebülize beta agonist+sistemik steroid uygulanmıştır. Hastaların nabız, solunum sayısı, oksijen satürasyonu ve solunum skoru değerleri ilk başvuruda, 1-2-3. dozlardan sonra ve tedavi bitiminden 2 saat sonra değerlendirilmiştir.

Bulgular: Hastaların yaş ortalaması 6.4±3.4 ay olup, erkek/kız oranı 6,7 olarak belirlenmiştir.

Tedavi grupları kendi içinde ve dozlar arası değerlendirildiğinde; nabız, solunum sayısı, oksijen satürasyonu ve solunum skoru parametrelerinde tüm gruplar için düzelme olduğu saptanmıştır (p<0.05). Yalnızca nebülize beta agonist verilmesine kıyasla nebülize beta agoniste nebülize steroid veya sistemik steroid eklenmesinin nabız ve solunum skorunda daha iyi düzelme sağla- dığı saptanmıştır (p<0.05). Ancak, eklenen steroidin nebülize ya da sistemik olması fark yarat- mamıştır (p>0,05). Hospitalizasyon oranları steroid eklenen gruplarda %18 ve %17 iken, yal- nızca nebülize beta agonist uygulanan grupta daha yüksek (%36) bulunmuştur (p<0.05).

Sonuç: Akut bronşiyolit tedavisinde hem bronkodilatatörler hem de steroidler etkili bulunmuş- tur. Bronkodilatörlere inhale ya da sistemik steroid eklenmesi ile etkinlik artmakta ve hospita- lizasyon oranı azalmaktadır. Ancak, bu ajanların akut bronşiyolit tedavisindeki yerini belirle- mek için kontrol grubu ile karşılaştıran çalışmalara gerek vardır.

Anahtar kelimeler: Akut bronşiyolit, tedavi, steroid, salbutamol ABSTRACT

Objective: Nebulized beta agonist, nebulized steroid and systemic steroids are being used in acute bronchiolitis treatment, but there is no consensus on the efficiacy of this regimen. In this study, comparison of clinical efficacies of these agents with uncertain outcomes was planned.

Material and Methods: The study was done with 360 children aged 2 months to 2 years who were admitted to the Emergency Department with the diagnosis of acute bronchiolitis. Patients were randomly assigned to 3 treatment groups; Group A was given 3 consecutive doses of nebulized beta agonist, Group B nebulized beta agonist + a nebulized steroid and Group C nebulized beta agonist + a systemic steroid. Pulse rate, respiratory rate, oxygen saturation and respiratory score were recorded at the admission, after 1st, 2nd and 3rd doses and 2 hours following the termination of the treatment.

Results: Mean age of the patients was 6.4±3.4 years, and girls/boys ratio was 6.7. In intergroup comparisons, a nebulized beta agonist plus a nebulized steroid or a asystemic steroid had yiel- ded better results than a nebulized beta agonist alone with respect to pulse rate and respiratory score in all comparator groups (p<0.05). However nebulized steroid or systemic steroid as an adjunct therapy caused no intergroup differences (p>0.05). Need for hospitalization in steroid groups were 18% and 17% which was significantly higher in nebulized beta agonist only group (36%) (p<0.05).

Conclusion: Both bronchodilators and steroids were found to be effective in the treatment of acute bronchiolitis Addition of inhaled or systemic steroids to the existing therapy increased efficacy of treatment and decreased the need for hospitalization. In order to define the role of these medications in the treatment of acute bronchiolitis, studies performed with comparator control groups are needed.

Key words: Acute bronchiolitis, treatment, salbutamol, steroid

$O×QG×ù×WDULK13.07.2011 .DEXOWDULKL25.07.2011

<D]×üPDDGUHVLDoç. Dr. Demet Can, Dr. Behçet 8] dRFXN +DVWDO×NODU× YH &HUUDKLVL (ùLWLP YH

$UDüW×UPD+DVWDQHVLú]PLU GGFDQ#KRWPDLOFRP

$NXWEURQüL\ROLWWHGDYLVLQGHQHEOL]HVDOEXWDPRO

QHEOL]HVWHURLGYHVLVWHPLNVWHURLGLQ

NDUü×ODüW×U×OPDV×

&RPSDULVRQRIQHEXOL]HGVDOEXWDPROQHEXOL]HGVWHURLGDQG

V\VWHPLFVWHURLGLQDFXWHEURQFKLROLWLVWUHDWPHQW

%DQX*OFDQ2185)VXQ$7/,+$1'HPHW&$16XQD$6ú/62<1HVULQ*h/(=+DVDQ$ø,1 'U%HKoHW8]dRFXN+DVWDO×NODU×YH&HUUDKLVL(ùLWLPYH$UDüW×UPD+DVWDQHVLú]PLU

58

(2)

 *ú5úû

 6WoRFXNOXùXG|QHPLQGHHQV×NJ|UOHQYHKRVSL- WDOL]DV\RQ JHUHNWLUHQ DOW VROXQXP \ROX LQIHNVL\RQX

DNXW EURQüL\ROLWWLU $NXW EURQüL\ROLWWH RODV× NRPSOL- NDV\RQODU×Q |QOHQPHVL LoLQ GLNNDWOL L]OHP YH GHVWHN

WHGDYL|QHULOPHNWHGLU$NXWEURQüL\ROLWV×UDV×QGDJHOL- üHQ EURQNRNRQVWUNVL\RQ LoLQ ORNDO \D GD VLVWHPLN

EHWDDJRQLVWOHUYHVWHURLGOHUNXOODQ×OPDNODELUOLNWHEX

PHGLNDO DMDQODU×Q WHGDYLGHNL \HUL WDUW×üPDO×G×U(1-3).

%XJQHNDGDUSHNoRNLODooDO×üPDV×\DS×OP×üYHEX

LODoODU×HWNLQOLNOHULEL\R\DUDUODQ×PODU×YH\DQHWNLOHUL

Do×V×QGDQ oRN oHüLWOL VRQXoODU HOGH HGLOPLüWLU %X

oDO×üPDODU×Q GHùHUOHQGLULOGLùL PHWD DQDOL]OHUGH DNXW

EURQüL\ROLWWH KLoELU PHGLNDO DMDQ×Q HWNLOL ROPDG×ù×

\DOQ×]FDGHVWHNWHGDYLYHULOPHVLQLQ\HWHUOLRODELOHFH- ùLELOGLULOPHNWHGLU(4-6).

 dDO×üPDP×]GDDNXWEURQüL\ROLWWHGDYLVLQGHWDUW×ü- PDO× RODQ QHEOL]H EHWD DJRQLVWOHULQ QHEOL]H \D GD

VLVWHPLN VWHURLGOHULQ HWNLQOLNOHULQLQ NDUü×ODüW×U×OPDV×

DPDoODQP×ü QHEOL]H EHWD DJRQLVWH VLVWHPLN YH\D

QHEOL]H VWHURLG HNOHQPHVLQLQ NOLQLN HWNLQOLN Do×V×Q- GDQ\DUDWW×ù×IDUNO×O×NDUDüW×U×OP×üW×U

 *(5(dYH<g17(0

 +DVWDVHoLPL

 5DQGRPL]H NHVLWVHO Do×N oDO×üPD\D 

 WDULKOHUL DUDV×QGD DFLO J|]OHP QLWHVLQH

DNXWEURQüL\ROLWWDQ×V×LOH\DW×U×ODQoRFXNDO×QP×ü- W×U dDO×üPD LoLQ LOJLOL NXUXOODUGDQ L]LQ YH DLOHOHUGHQ

RQDP IRUPX DO×QP×üW×U dDO×üPD\D DO×QPD NULWHUOHUL

KDVWDQ×Q  D\ \Dü DUDV×QGD ROPDV× YLUDO VW VROX- QXP\ROXLQIHNVL\RQXEXOJXODU× DWHüEXUXQDN×QW×V×

NRUL]D |NVUN IDULQNVWH KLSHUHPL  LOH ELUOLNWH LON

K×ü×OW× DWDù× ROPDV× GL\H EHOLUOHQPLüWLU dDO×üPD\D

|\NGH SUHPDWULWH \HQLGRùDQ G|QHPLQGHVROXQXP

V×N×QW×V×QHGHQL\OHVDùO×NPHUNH]LQHEDüYXUX\LQHOH-

\HQ K×ü×OW× NURQLN NDOS YH VROXQXP \ROX KDVWDO×ù×

RODQPXD\HQHV×UDV×QGDQ|URORMLN\DGD\DS×VDOPDO- IRUPDV\RQ VDSWDQDQ oRFXNODU DO×QPDP×üW×U úON EDü- YXUX EXOJXODU× LOH DNXW EURQüL\ROLW LoLQ KDVWDQH\H

\DW×üNULWHUOHULQHVDKLSKDVWDODUDFLOVHUYLVH\DW×U×OP×ü

oDO×üPD\D GDKLO HGLOPHPLüWLU(7) dDO×üPD\D DO×QPD

NULWHUOHULQH X\DQ KDVWDODU×Q QDE×] VROXQXP VD\×V×

RNVLMHQVDWUDV\RQXYHVROXQXPVNRUXEHOLUOHQPLüWLU

6ROXQXP JoOùQ REMHNWLI RODUDN GHùHUOHQGLUPHN

LoLQ 6ROXQXP *oOùQ 'HùHUOHQGLUPH 6NRUX

5HVSLUDWRU\'LVWUHVV$VVHVVPHQW,QVWUXPHQW5'$,  NXOODQ×OP×üW×U 7DEOR   5'$,VNRUXDUDV×Q- GDRUWDGHUHFHGHVROXQXPV×N×QW×V×RODQROJXODUoDO×ü- PD\DDO×QP×üW×U

 7HGDYLSURWRNRO

 dDO×üPD NULWHUOHULQH X\DQ  KDVWD UDQGRPL]H

RODUDN KHU JUXSWD  KDVWD RODFDN üHNLOGH  JUXED

D\U×OP×üW×U

 *UXS$·\D  GN DUD LOH DUG×ü×N  GR] QHEOL]H

VDOEXWDPRO 9HQWROLQ QHEXOHVŠ  PJNJGR]

PD[PJ 

 *UXS %·\H  GN DUD LOH DUG×ü×N  GR] QHEOL]H

VDOEXWDPROGR]QHEOL]HVDOEXWDPROLOHELUOLNWH

QHEOL]H IOXWLND]RQ SURSL\RQDW )OL[RWLGH 

QHEXOHVŠPJGR] 

7DEOR6ROXQXPJoOùQGHùHUOHQGLUPHVNRUX 5'$, 

+×ü×OW×

5HWUDNVL\RQODU

0

Yok Yok Yok

Yok Yok Yok



Sonunda .×VPL Yer Yer

+DILI +DILI +DILI (NVSLU\XPGD

úQVSLU\XPGD /RNDOL]DV\RQX

6XSUDNODYLNXOHU úQWHUNRVWDO 6XENRVWDO

2

ô·VLQGH 7DPDP×

7P

Orta Orta Orta

3 ö·QGH

&LGGL

&LGGL

&LGGL

4 7DPDP×

(3)

 *UXS &·\H  GN DUD LOH DUG×ü×N RODUDN QHEOL]H

VDOEXWDPROLOHGR]QHEOL]HVDOEXWDPROELUOLNWH

VLVWHPLN SUHGQL]RORQ 3UHGQROO  PJŠ  PJ

NJGR],0 X\JXODQP×üW×U

 +HU KDVWDQ×Q NDOS WHSH DW×P× VROXQXP VD\×V×

RNVLMHQVDWUDV\RQXYH5'$,VNRUXGHùHUOHULLONEDü- YXUXGD  GR]ODUGDQ VRQUDNL  GN·GD YH 

GR]GDQVDDWVRQUDGHùHUOHQGLULOPLüWLU'HùHUOHQGLU

PHVRQXFXND\GHGLOHQEXSDUDPHWUHOHU×ü×ù×QGDWHGD- YL JUXSODU× NDUü×ODüW×U×OP×üW×U 6RQ GHùHUOHQGLUPHGH

5'$,VNRUX·QLQDOW×QGDRODQKDVWDODUWDEXUFXHGLO- PLü5'$,VNRUXYHVWQGHGHYDPHGHQKDVWDODU

LVHDFLOVHUYLVH\DW×U×OP×üW×U

 9HULOHULQ LVWDWLVWLNVHO DQDOL]L LoLQ 6366 SURJUDP×

NXOODQ×ODUDN NLNDUH WHVWL WHN \|QO YDU\DQV DQDOL]L

7XFNH\+6'LOHULDQDOL]WHVWL6WXGHQW7WHVWLX\JX- ODQP×üW×U

%8/*8/$5

 dDO×üPD\D DO×QDQ  KDVWDQ×Q \Dü RUWDODPDV×

“ D\ ROXS HUNHNN×] RUDQ×  RODUDN VDSWDQ- P×üW×U7HGDYL JUXSODU×QD J|UH KDVWDODU×QJHQHO |]HO- OLNOHUL7DEOR·GHJ|VWHULOPLüWLU

 2OJXODU×Q EDüYXUX ]DPDQ×Q×Q HQ oRN RFDN D\×

 ROPDN]HUHN×üD\ODU×QGDHQD]EDüYXUXQXQ

LVH$ùXVWRVD\×  ROPDN]HUH\D]D\ODU×QGDROGX- ùXVDSWDQP×üW×U

 %DüYXUX\DN×QPDODU×GHùHUOHQGLULOGLùLQGHKDVWDOD- U×Q EDüYXUXGDQ |QFH ·V×QGD DWHü ·QGH

EXUXQ DN×QW×V× ·LQGH |NVUN YH ·VLQGH

QHIHV DOPDGD ]RUOXN YH\D K×ü×OW× WDULI HGLOGLùL EHOLU- OHQPLüWLU 2OJXODU×Q FLQVL\HWOHUL EDüYXUXODU×QGDNL

DWHü EXUXQ DN×QW×V× K×ü×OW× GLVSQH YH |NVUN JLEL

\DN×QPDODU× Do×V×QGDQ JUXSODU DUDV×QGD LVWDWLVWLNVHO

RODUDNIDUNO×O×NEXOXQPDP×üW×U S! 7HGDYLJUXS- ODU×Q×QoDO×üPDQ×QEDüODQJ×F×QGDGHùHUOHQGLULOHQNDOS

WHSHDW×PVD\×V×VROXQXPVD\×V×RNVLMHQVDWUDV\RQX

YH 5'$, VNRUX RUWDODPDODU× 7DEOR ·WH J|VWHULOPLü

JUXSODUDUDV×QGDEXSDUDPHWUHOHUDo×V×QGDQLVWDWLVWLN- VHORODUDNDQODPO×IDUNO×O×NVDSWDQPDP×üW×U S! 

 *HQHORODUDNWPWHGDYLJUXSODU×QGDJUXSODUNHQGL

LoLQGHYHGR]ODUDUDV×GHùHUOHQGLULOGLùLQGHNDOSWHSH

DW×P×VROXQXPVD\×V×RNVLMHQVDWUDV\RQXYH5'$,

VNRUX SDUDPHWUHOHULQGH WHGDYL YHULOPHVL VRQXFX

G]HOPHROGXùXVDSWDQP×üW×U S 

 úON GR] VDOEXWDPRO VRQUDV× WP JUXSODUGD NDOS

7DEOR7HGDYLJUXSODU×QDJ|UHKDVWDODU×QJHQHO|]HOOLNOHUL

*UXS$

*UXS%

*UXS&

7RSODP

(UNHN

76 (%63,3) 75 (%62,5)

 

 

<Dü 2UW“6'

6,42±3,32 6,26±3,21 6,63±3,67 6,43±3,40 .×]

44 (%36,7) 45 (%37,5) 41 (%34,2) 130 (%36,1)

7DEOR  dDO×üPDQ×Q EDüODQJ×F×QGDNL GHùHUOHQGLUPH SDUD- PHWUHOHULQLQJUXSODUDJ|UHGDù×O×P×

.DOSWHSH

DW×P× GN

Solunum VD\×V× GN

SaO2 5'$,

*UXS&

145,2±17,2 45,5±10,7

“

“

7RSODP

“

“

“

10,2±2,3

*UXS%

“

“

“

10,5±2,5

*UXS$

144,7±16,6

“

“

10,3±2,0

7DEOR7HGDYLEDVDPDNODU×QGDVDSWDQDQ5'$,RUWDODPDOD- U×Q×QJUXSODUDJ|UHGDù×O×P×

*UXS$

*UXS%

*UXS&

7RSODP

GR]

VRQUDV×

6,1±2,7 4,7±2,5 5,1±2,5 5,3±2,6

GR]

VRQUDV×

5,5±3,0 3,3±2,5 3,7±2,7

“

GR]

VRQUDV×

7,5±2,6 7,2±2,2 7,0±2,2 7,2±2,3 úON

JHOLü

10,3±2,0 10,5±2,5

“

10,2±2,3

GR]GDQ

VDDWVRQUD

“

“

3,2±3,0 3,6±3,1

7DEOR  7HGDYL EDVDPDNODU×QGD VDSWDQDQ VROXQXP VD\×V×

RUWDODPDODU×Q×QJUXSODUDJ|UHGDù×O×P×

*UXS$

*UXS%

*UXS&

7RSODP

GR]

VRQUDV×

“

“

“

“

GR]

VRQUDV×

“

“

“

“

GR]

VRQUDV×

42,2±10,7

“

“

“

úON

JHOLü

“

“

“

“

GR]GDQ

VDDWVRQUD

33,2±10,0

“

“

“

60

(4)

WHSH DW×P× VROXQXP VD\×V× 5'$, VNRUXQGD DQODPO×

GüPHRNVLMHQVDWUDV\RQXQGDLVHDQODPO×\NVHOPH

J|]OHQPLüWLU 7HGDYL JUXSODU× DUDV×QGD NOLQLN L]OHP

SDUDPHWUHOHUL \|QQGHQ IDUNO×O×N  GR]GDQ VRQUD

RUWD\Do×NP×üW×U*UXS%·GHNDOSWHSHDW×P× S   YH 5'$, VNRUXQGD S   *UXS $·\D N×\DVOD

DQODPO×RODUDNGüPH*UXS&·GHLVHVROXQXPVD\×- V×QGD *UXS$·\D J|UH DQODPO× RODUDN GüPH VDSWDQ- P×üW×U S  2NVLMHQVDWUDV\RQXDo×V×QGDQWP

oDO×üPDER\XQFD*UXS$·GD*UXS%·\HJ|UH S   YH*UXS&·\HJ|UH S  DQODPO×VD\×GDGDKDD]

G]HOPH ROGXùX J|]OHQPLüWLU S!  *UXS $·GD

*UXS %·\H J|UH S   YH *UXS &·\H J|UH

S   DQODPO× VD\×GD GDKD ID]OD WDüLNDUGL JHOLü- PLüYHWDüLNDUGLGH*UXS%·\HJ|UH S  YH*UXS

&·\H J|UH S   GDKD D] G]HOPH J|]OHQPLüWLU

1HEOL]H\DGDSDUHQWHUDOVWHURLGHNOHQHQ*UXS%YH

*UXS&DUDV×QGDKLoELUL]OHPSDUDPHWUHVLQGHDQODPO×

IDUNO×O×N ROXüPDG×ù× EHOLUOHQPLüWLU S!  7HGDYL

EDVDPDNODU×QGDVDSWDQDQ5'$,RUWDODPDODU×Q×QJUXS- ODUDJ|UHGDù×O×P×7DEOR·WHVROXQXPVD\×V×RUWDOD- PDODU×Q×QJUXSODUDJ|UHGDù×O×P×7DEOR·WHJ|VWHULO- PLüWLU

 +DVWDODU×Q ·X WHGDYL\H \DQ×WV×] NDOP×ü YH

KRVSLWDOL]H HGLOPLüWLU +RVSLWDOL]DV\RQ RUDQODU×QD

EDN×OG×ù×QGD VWHURLG HNOHQHQ *UXS % YH *UXS &·GH

  \DOQ×]FD VDOEXWDPRO X\JXODQDQ *UXS

$·\D   J|UH \DW×ü RUDQODU×Q×Q GDKD D] ROGXùX

J|]OHQPLüWLU S $QFDN*UXS%YH*UXS&·GH

\DW×ü RUDQODU× Do×V×QGDQ DQODPO× IDUNO×O×N ROPDG×ù×

VDSWDQP×üW×U S! 

 7$57,û0$

 $NXWEURQüL\ROLWWHKLSRNVL\LKDYD\ROXREVWUNVL-

\RQXYHYHQWLODV\RQSHUI]\RQGHQJHVL]OLùLPH\GDQD

JHWLULU7HGDYLQLQDQDDPDF×GLNNDWOLPRQLWRUL]DV\RQ

KDYD \ROX Do×NO×ù×Q×Q GHYDP× YH \HWHUOL V×Y× GHVWHùL

LOHKDVWD\×KLSRNVLYHVROXQXP\HWPH]OLùLQGHQNRUX- PDNW×U %X QHGHQOH SXOVH RNVLPHWUH LOH QRQ LQYD]LY

ELU üHNLOGH RNVLMHQ VDWUDV\RQX WDNLEL \DS×ODUDN

KLSRNVL GHùHUOHQGLULOLU $QFDN \DOQ×]FD SXOVH RNVL-

PHWUHLOHL]OHP\HWHUOLGHùLOGLUNoNKDYD\ROODU×Q×Q

GLUHQFL GH GHùHUOHQGLULOPHOLGLU %X GHùHUOHQGLUPH

LoLQVROXQXPVD\×V×YHVROXQXPVNRUXNXOODQ×O×U  . dDO×üPDP×]GDKDVWDO×ù×QJLGLüLQLEHOLUOHPHNYHWHGD- YL\H \DQ×W× GHùHUOHQGLUPHN LoLQ RNVLMHQ VDWUDV\RQX

\DQ× V×UD VROXQXP VD\×V× YH VROXQXP VNRUX 5'$,  NXOODQ×OP×üW×U

 dDO×üPD\D DO×QDQ ROJXODU×Q FLQVL\HWOHUL EDüYXUX- ODU×QGDVDSWDQDQDWHüEXUXQDN×QW×V×K×ü×OW×GLVSQHYH

|NVUN JLEL \DN×QPDODU× Do×V×QGDQ WHGDYL JUXSODU×

DUDV×QGD LVWDWLVWLNVHO RODUDN IDUNO×O×N EXOXQPDP×üW×U

$\Q×üHNLOGHJUXSODUDUDV×QGDoDO×üPDQ×QEDüODQJ×F×Q- GD GHùHUOHQGLULOHQ NDOS WHSH DW×P VD\×V× VROXQXP

VD\×V×RNVLMHQVDWUDV\RQXYH5'$,VNRUXJLELSDUD- PHWUHOHUDo×V×QGDQLVWDWLVWLNVHORODUDNDQODPO×IDUNO×- O×N VDSWDQPDP×üW×U %X GXUXP oDO×üPD JUXSODU×Q×Q

LVWDWLVWLNVHORODUDNNDUü×ODüW×U×ODELOLUJUXSODUROGXùXQX

J|VWHUPLüWLU

 $NXW EURQüL\ROLW WHGDYLVLQGH QHEOL]H WHGDYL LOH

ELUOLNWH RNVLMHQ WHGDYLVL YHULOPHVLQLQ |QHPL \DS×ODQ

oDO×üPDODUGDYXUJXODQP×üW×U(11)%L]LPoDO×üPDP×]GD

GDWHGDYLYHL]OHPV×UDV×QGDRGDKDYDV×QGDNLRNVLMHQ

VDWUDV\RQ GHùHUOHUL ·Q DOW×QGD ROGXùXQGD

PDVNHLOHRNVLMHQWHGDYLVLX\JXODQP×üW×U

 $NXW EURQüL\ROLWWHNL REVWUNVL\RQXQ DV×O QHGHQL- QLQ LQIODPDV\RQ PXNR]DO |GHP YH PXNXV SODNODU×

QHGHQL\OHGDUDODQNoNKDYD\ROODU×ROPDV×QHGHQL\- OH EURQNRGLODW|UOHULQ HWNLVL] RODFDù× GüQOU(12).

$QFDN oDO×üPDP×]GD LON GR] EHWD DJRQLVWL DODQ 

WHGDYLJUXEXQGDGDGN·GDVROXQXPVD\×V×VROX- QXPVNRUXYHRNVLMHQVDWUDV\RQXQGDN×VPLG]HOPH

J|UOPü \DOQ×]FD EHWD DJRQLVW DODQ JUXSWD WHGDYL

WDPDPODQG×ù×QGD EDüODQJ×o SDUDPHWUHOHULQH J|UH

EHOLUJLQG]HOPHND\GHGLOPLüWLU<LQHGHDNXWEURQüL-

\ROLWWHGDYLVLQGHEHWDDJRQLVWOHULQWHNEDü×QDHWNLQOL- ùLQLJ|VWHUPHNLoLQSODVHERLOHNDUü×ODüW×UPDO×oDO×ü- PDODUD JHUHN YDUG×U dDO×üPDP×]GD HWLN QHGHQOHUOH

SODVHERNXOODQ×OPDP×üW×U

 $NXW EURQüL\ROLW WHGDYLVLQGH WDUW×üPDO× ROVD GD

VLVWHPLN YH LQKDOH VWHURLGOHU NXOODQ×OPDNWDG×U(7,12). dDO×üPDP×]GDEHWDDJRQLVWHHNRODUDNVLVWHPLN\DGD

LQKDOH VWHURLG NXOODQ×OPDV×Q×Q NDOS WHSH DW×P× YH

(5)

VROXQXP VD\×V×QGD GüPH RNVLMHQ VDWUDV\RQXQGD

LVH\NVHOPH\HQHGHQROGXùXJ|]OHQPLüWLU7HNEDü×- QDEHWDDJRQLVWNXOODQ×OPDV×QDJ|UHDQODPO×RODQEX

VRQXoODUNXOODQ×ODQVWHURLGLQVLVWHPLN\DGDQHEOL]H

ROPDV×QGDQ HWNLOHQPHPLüWLU <LQH VWHURLG NXOODQ×ODQ

ROJXODUGDKDVWDQH\H\DW×üRUDQ×Q×Q\DOQ×]FDEHWDDJR- QLVWNXOODQ×ODQROJXODUDJ|UHGDKDD]ROGXùXVDSWDQ- P×üW×U+DVWDQH\H\DW×üULVNLQLQD]DOPDV×HOEHWWHDNXW

EURQüL\ROLW SURJQR]X ]HULQGH ROXPOX HWNL \DSDFDN- W×U 6WHURLG X\JXODQDQ JUXSODU DUDV×QGD KRVSLWDOL]DV-

\RQRUDQODU×Do×V×QGDQIDUNVDSWDQPDPDV×QHGHQL\OH

VLVWHPLN\DGDQHEOL]HVWHURLGX\JXODPDV×Q×QELUEL- ULQH VWQ ROPDG×ù× EHOLUOHQPLüWLU$QFDN EHWD DJR- QLVWOHUGHROGXùXJLELKHPVWHURLGOHULQHWNLVLKHPGH

IDUNO× VWHURLG WLSOHULQLQ HWNLQOLùLQL DUDüW×UPDN LoLQ

SODVHERLOHNDUü×ODüW×UPDO×oDO×üPDODUDJHUHNYDUG×U

 6RQXo RODUDN EHWD DJRQLVW YH VWHURLGOHULQ DNXW

EURQüL\ROLWWHNLHWNLQOLNOHULKDOHQWDUW×ü×OPDNODEHUDEHU

oDO×üPDP×]GDKHPEHWDDJRQLVWOHUKHPGHVWHURLGOHU- OH WHGDYL\H \DQ×W DO×QP×üW×U 6DOEXWDPROQ VDùODP×ü

ROGXùX EURQNRGLODWDV\RQXQ VWHURLG HNOHQPHVL LOH

GDKD GD EHOLUJLQOHüWLùL E|\OHFH KHP NOLQLN G]HOPH

VDùODQG×ù× KHP GH KRVSLWDOL]DV\RQ ULVNLQLQ D]DOG×ù×

VDSWDQP×üW×U %URQNRGLODW|U WHGDYL\H VLVWHPLN \D GD

QHEOL]H VWHURLG HNOHQPHVLQLQ JHWLUGLùL ROXPOX HWNL- OHULQ ELUELULQH VWQ ROPDG×ù× GüQOUVH VLVWHPLN

VWHURLGPDOL\HWHWNLQROPDV×QHGHQL\OHVHoLOHELOLU

 .$<1$./$5

 3KHODQ3'2OLQVN\$5REHUWVRQ&)HGV5HVSLUDWRU\LOOQHVV

LQFKLOGUHQWKHG2[IRUG%ODFNZHOO6FLHQWLILF3XEOLFDWLRQV



 :DLQZULJKW &$FXWH YLUDO EURQFKLROLWLV LQ FKLOGUHQ D YHU\

FRPPRQ FRQGLWLRQ ZLWK IHZ WKHUDSHXWLF RSWLRQV 3DHGLDWU

5HVSLU5HY

 KWWSG[GRLRUJMSUUY

 30LG

 :RKO 0(% %URQFKLROLW ,Q &KHUQLFN 9 %RDW 7) HGV

.HQGLJ·V'LVRUGHUVRIWKH5HVSLUDWRU\7UDFWLQ&KLOGUHQWK

HGLWLRQ3KLODGHOSKLD:%6DXQGHUV

 *DGRPVNL$0%URZHU0%URQFKRGLODWRUVIRUEURQFKLROLWLV

&RFKUDQH'DWDEDVH6\VW5HY  &'

 )HUQDQGHV50%LDO\/09DQGHUPHHU%7MRVYROG/3OLQW

$& 3DWHO + -RKQVRQ ': .ODVVHQ 73 +DUWOLQJ /

*OXFRFRUWLFRLGV IRU DFXWH YLUDO EURQFKLROLWLV LQ LQIDQWV DQG

\RXQJ FKLOGUHQ &RFKUDQH 'DWDEDVH 6\VW 5HY

  &'

 )LW]JHUDOG '$ .LOKDP +$ %URQFKLROLWLV DVVHVVPHQW DQG

HYLGHQFHEDVHGPHGLFLQH0-$

 30LG

 dRNXùUDü + .DUDGDù % 'DùO× ( YH DUN 7RUDNV 'HUQHùL

$NXWEURQüL\ROLWWDQ×YHWHGDYLUHKEHUL

 0XOO&&6FDUIRQH5-)HUUL/5HWDO$UDQGRPL]HGWULDORI

QHEXOL]HGHSLQHSKULQHYVDOEXWHUROLQWKHHPHUJHQF\GHSDUW- PHQW WUHDWPHQW RI EURQFKLROLWLV $UFK 3HGLDWU $GROHVF 0HG



 KWWSG[GRLRUJDUFKSHGL

 30LG

 6KDZ.1%HOO/06KHUPDQ1+2XWSDWLHQWDVVHVVPHQWRI

LQIDQWV ZLWK EURQFKLROLWLV $P - 'LV &KLOG 

155.

 30LG

%LDO\ / 6PLWK 0 %RXUNH 7 %HFNHU / 7KH &RFKUDQH

/LEUDU\ DQG EURQFKLROLWLV DQ XPEUHOOD UHYLHZ (YLG%DVHG

&KLOG+HDOWK,

 KWWSG[GRLRUJHEFK

 $PHULFDQ$FDGHP\RI3HGLDWULFV'LDJQRVLVDQG0DQDJHPHQW

RI%URQFKLROLWLV3HGLDWULFV²

 KWWSG[GRLRUJSHGV

 30LG

.LQJ 9- 9LVZDQDWKDQ 0 %RUGOH\ & HW DO 3KDUPDFRORJLF

WUHDWPHQW RI EURQFKLROLWLV LQ LQIDQWV DQG FKLOGUHQ $UFK

3HGLDWU$GROHVF0HG

 KWWSG[GRLRUJDUFKSHGL

 30LG

62

Referanslar

Benzer Belgeler

• Aromataz inhibitörleri östrojen sentezini sağlayan aromataz enzimini bloke ederek östrojenik hormon düzeylerini azaltmayı amaçlamaktadır. • Günümüzde kullanılan

Prostat kanseri, erkeklerde şiddetli seksüel dürtü ve seksüel sapma (parafili) tedavisi ile kadınlarda testosteron üstünlüğüne bağlı akne ve hirsutizm tedavisinde

Addison hastalığı ve benzeri adrenal yetmezliklerde veya sistemik antienflamatuar etki sağlamak amacıyla oral veya rektal, ayrıca enflamasyonlu veya alerjik cilt

Yazışma Adresi/Address for Correspondence: Halise Akça, Ankara Yıldırım Beyazıt Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Acil

Stero- id erken kesilmesi (&lt;3 ay posttransplant) veya stero- id içermeyen tedavi, rejeksiyon riski düşük (ilk kez nakil olanlar, canlı donörden nakiller, doku uyumu- nun iyi

Hastaların gestasyon yaşları ortalama 26,81±1,87 (24-31) hafta, yatış süresi ortalama 77,5±12,92 (23-142) gün, steroid tedavi süresi ortalama 7,85±3,43 (3-11) gün,

Prebronkodilatör FEV 1 değeri &lt; %60 olan GOLD orta- çok ağır KOAH olgularında İKS/LABA fiks kombinas- yonu ile yapılan üç yıl süren çalışmada kombinasyon tedavisinin FEV

This meta-analysis was performed with the data of 49.906 subjects randomized to formoterol group and 18.098 subjects not randomized to long acting beta- agonist treatment in